Publications (36) FRANCISCO JOSE HERMIDA PRADO publications

filter_list

2025

  1. CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer

    Signal Transduction and Targeted Therapy, Vol. 10, Núm. 1

  2. Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor–positive breast cancer

    JCI Insight , Vol. 10, Núm. 12

  3. Tamoxifen induces PI3K activation in uterine cancer

    Nature Genetics, Vol. 57, Núm. 9, pp. 2192-2202

2024

  1. Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  2. Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer

    npj Breast Cancer, Vol. 10, Núm. 1

  3. Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 9, pp. 1889-1905

  4. Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis

    Journal of translational medicine, Vol. 22, Núm. 1, pp. 135

2023

  1. Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer

    Cancer research, Vol. 83, Núm. 19, pp. 3284-3304

  3. Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer

    Cancer research, Vol. 82, Núm. 20, pp. 3673-3686

  2. Pathobiological functions and clinical implications of annexin dysregulation in human cancers

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. The ESR1 Mutations: From Bedside to Bench to Bedside

    Cancer Research

  2. Tumor-infiltrating cd20+ b lymphocytes: Significance and prognostic implications in oral cancer microenvironment

    Cancers, Vol. 13, Núm. 3, pp. 1-16

2020

  1. Expression of E-cadherin and β-catenin in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas

    Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 6, pp. 358-366

  2. Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma

    Oral Oncology, Vol. 110

  3. Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma

    Biomedicines, Vol. 8, Núm. 12, pp. 1-14

  4. Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas

    Cancers, Vol. 12, Núm. 7, pp. 1-15

2019

  1. Deciphering the molecular basis of melatonin protective effects on breast cells treated with doxorubicin: Twist1 a transcription factor involved in emt and metastasis, a novel target of melatonin

    Cancers, Vol. 11, Núm. 7

  2. MAPK inhibition and growth hormone: a promising therapy in XLH

    FASEB Journal, Vol. 33, Núm. 7, pp. 8349-8362